WebApr 11, 2024 · Innvolution, a group focused on interventional cardiology with a comprehensive portfolio of imaging and consumable products, announced today that it had raised growth capital from OrbiMed, a global healthcare-focused investment firm. The funds will be used to ramp up the R&D efforts, develop new products, and expand into … WebJonathan T. Silverstein, J.D./M.B.A., is a former Managing Partner and Co-Head of Global Private Equity at OrbiMed. He is currently an Executive Partner at OrbiMed, one of the world’s largest fully dedicated healthcare fund managers. Mr. Silverstein joined OrbiMed in 1999 and was on the board of several dozen biotech companies over the last ...
Emily Kalenik - Senior Associate - OrbiMed ZoomInfo
WebOrbiMed maintains its headquarters in New York City, with additional offices in San Francisco, Mumbai, Shanghai, and Herzliya. Additional information about OrbiMed can be found at www.orbimed.com. Investor Relations Contact Robert Allen Chief Financial Officer +1 508-846-0587 Email: [email protected] WebApr 11, 2024 · Dr Sunny Sharma and Ankesh Bhansali of OrbiMed are joining the board of Innvolution. Dr Sunny Sharma, Senior Managing Director, OrbiMed Asia, said, “Innvolution has created a strong and unique platform for cardiovascular care products in the country and has become one of the largest indigenous suppliers of Cath Labs. ... Media contact: … notre dame cathedral construction update
UCD spin-out raises €32.5m to develop pulmonary disease drug
WebOrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals to medical devices and diagnostics. 563 Investments 215 Exits 1989 Founding Year OrbiMed email information for free We’ve compiled OrbiMed contact information, along with 2,000+ more startup investors, in a single database just for you (for free!). WebOrbiMed (also known as OrbiMed Advisors) is an American investment firm based in New York City, United States. It is focused on making public and private investments in the … Web1 day ago · UCD spin-out Aer Therapeutics has raised $36 million (€32.5 million) to develop a drug for patients with chronic obstructive pulmonary disease (COPD). how to shave your legs reddit